<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, the most common form of <z:mp ids='MP_0002657'>chondrodysplasia</z:mp>, has been associated with mutations in the gene of the fibroblast growth factor receptor-3 (FGFR-3) on chromosome 4p </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 39 achondroplasia alleles studied so far carried point mutations which caused the same amino acid exchange, a substitution of glycine by arginine at position 380 (G380R) in the transmembrane domain of the receptor </plain></SENT>
<SENT sid="2" pm="."><plain>We report on a newborn with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> who does not carry a G380R mutation but has a mutation causing substitution of a nearby glycine with a cysteine (G375C) </plain></SENT>
<SENT sid="3" pm="."><plain>This observation indicates allelic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> and confirms the role of mutations in the transmembrane domain of FGFR-3 in the pathogenesis of <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
</text></document>